JP2002544234A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002544234A5 JP2002544234A5 JP2000617907A JP2000617907A JP2002544234A5 JP 2002544234 A5 JP2002544234 A5 JP 2002544234A5 JP 2000617907 A JP2000617907 A JP 2000617907A JP 2000617907 A JP2000617907 A JP 2000617907A JP 2002544234 A5 JP2002544234 A5 JP 2002544234A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- bone marrow
- brain
- spinal cord
- marrow stromal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004556 brain Anatomy 0.000 description 14
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 12
- 239000003814 drug Substances 0.000 description 11
- 210000000278 spinal cord Anatomy 0.000 description 9
- 210000002569 neuron Anatomy 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 210000001185 bone marrow Anatomy 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000002054 transplantation Methods 0.000 description 5
- 210000003169 central nervous system Anatomy 0.000 description 4
- 210000004958 brain cell Anatomy 0.000 description 3
- 208000029028 brain injury Diseases 0.000 description 3
- 208000020431 spinal cord injury Diseases 0.000 description 3
- 210000000130 stem cell Anatomy 0.000 description 3
- 208000018737 Parkinson disease Diseases 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000001361 intraarterial administration Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 2
- 230000004770 neurodegeneration Effects 0.000 description 2
- 208000015122 neurodegenerative disease Diseases 0.000 description 2
- 230000000626 neurodegenerative effect Effects 0.000 description 2
- 210000004738 parenchymal cell Anatomy 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13434499P | 1999-05-14 | 1999-05-14 | |
| US60/134,344 | 1999-05-14 | ||
| PCT/US2000/012875 WO2000069448A1 (en) | 1999-05-14 | 2000-05-11 | Bone marrow transplantation for treatment of stroke |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002544234A JP2002544234A (ja) | 2002-12-24 |
| JP2002544234A5 true JP2002544234A5 (enExample) | 2010-09-16 |
Family
ID=22462927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000617907A Pending JP2002544234A (ja) | 1999-05-14 | 2000-05-11 | 発作の処置のための骨髄移植 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20090162327A1 (enExample) |
| EP (1) | EP1183035B1 (enExample) |
| JP (1) | JP2002544234A (enExample) |
| AU (1) | AU780994B2 (enExample) |
| CA (1) | CA2373808C (enExample) |
| DK (1) | DK1183035T3 (enExample) |
| ES (1) | ES2531592T3 (enExample) |
| PT (1) | PT1183035E (enExample) |
| WO (1) | WO2000069448A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6653134B2 (en) * | 1995-03-28 | 2003-11-25 | Cp Hahnemann University | Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| US20050169896A1 (en) * | 1999-05-14 | 2005-08-04 | Henry Ford Health System | Bone marrow transplantation for treatment of stroke |
| US8017112B2 (en) | 1999-05-14 | 2011-09-13 | Henry Ford Health System | Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases |
| US6749850B1 (en) | 1999-08-18 | 2004-06-15 | The General Hospital Corporation | Methods, compositions and kits for promoting recovery from damage to the central nervous system |
| WO2001012236A2 (en) * | 1999-08-18 | 2001-02-22 | The General Hospital Corporation | Methods, compositions and kits for promoting recovery from damage to the central nervous system |
| WO2001075094A1 (en) * | 2000-04-04 | 2001-10-11 | Thomas Jefferson University | Application of myeloid-origin cells to the nervous system |
| EP1302534A4 (en) * | 2000-06-26 | 2004-06-16 | Renomedix Inst Inc | CELL FRACTION WITH CELLS WHICH ARE ABLE TO DIFFERENTIATE IN NERVOUS CELLS |
| ES2180433B1 (es) * | 2001-05-28 | 2004-05-16 | Universidad Miguel Hernandez De Elche. | Empleo de celulas madre hematopoyeticas en la generacion de celulas madre neurales. |
| US9969980B2 (en) | 2001-09-21 | 2018-05-15 | Garnet Biotherapeutics | Cell populations which co-express CD49c and CD90 |
| WO2003038075A1 (en) * | 2001-10-30 | 2003-05-08 | Renomedix Institute Inc. | Method of inducing differentiation of mesodermal stem cells, es cells or immortalized cells into nervous system cells |
| WO2003056899A2 (en) | 2002-01-04 | 2003-07-17 | Henry Ford Health System | Nitric oxide donors for treatment of disease and injury |
| AU2003209259A1 (en) | 2002-01-14 | 2003-07-30 | The Board Of Trustees Of The University Of Illinois | Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| US9969977B2 (en) | 2002-09-20 | 2018-05-15 | Garnet Biotherapeutics | Cell populations which co-express CD49c and CD90 |
| JPWO2005007176A1 (ja) * | 2003-06-27 | 2006-08-31 | 株式会社レノメディクス研究所 | 間葉系細胞を有効成分とする体内投与用脳神経疾患治療薬 |
| US20060210544A1 (en) | 2003-06-27 | 2006-09-21 | Renomedix Institute, Inc. | Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient |
| RU2283121C2 (ru) * | 2004-11-29 | 2006-09-10 | Государственное учреждение Научно-исследовательский институт клинической иммунологии СО РАМН | Способ лечения инсульта |
| US20080107632A1 (en) * | 2006-09-06 | 2008-05-08 | Henrich Cheng | Fibrin glue composition for repairing nerve damage and methods thereof |
| EA201070022A1 (ru) | 2007-06-15 | 2010-06-30 | Гарнет Байотерапьютикс Инк. | Лечение заболеваний и нарушений с использованием самообновляющихся образующих колонии клеток, культивированных и размноженных in vitro |
| JP5276816B2 (ja) * | 2007-09-10 | 2013-08-28 | 肇 井上 | 神経機能改善剤 |
| US20110158969A1 (en) * | 2008-02-28 | 2011-06-30 | Henry Ford Health System | Compositions and methods for using stromal cells to enhance treatment of central nervous system injuries |
| CN107260760B (zh) * | 2013-02-06 | 2021-08-31 | Nc医学研究公司 | 用于治疗神经变性的细胞疗法 |
| US10336985B2 (en) * | 2013-10-14 | 2019-07-02 | Hadasit Medical Research Services & Development Limited | Method of obtaining terminally differentiated neuronal lineages and uses thereof |
| JPWO2015174087A1 (ja) * | 2014-05-16 | 2017-04-20 | 公益財団法人先端医療振興財団 | 脳梗塞の予防及び／又は治療の為の医薬 |
| RU2612981C1 (ru) * | 2015-12-21 | 2017-03-14 | Алексей Сергеевич Бывальцев | Способ лечения ишемического инсульта |
| US11464804B1 (en) | 2017-11-15 | 2022-10-11 | Enrico Stazzone | Intrathecal multifactorial infusion of heterogeneous autologous cell therapy |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4666828A (en) * | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
| US4683202A (en) * | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4801531A (en) * | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
| US5272057A (en) * | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
| US5192659A (en) * | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
| US5612211A (en) * | 1990-06-08 | 1997-03-18 | New York University | Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors |
| US5750376A (en) * | 1991-07-08 | 1998-05-12 | Neurospheres Holdings Ltd. | In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny |
| US5851832A (en) * | 1991-07-08 | 1998-12-22 | Neurospheres, Ltd. | In vitro growth and proliferation of multipotent neural stem cells and their progeny |
| AU690548B2 (en) * | 1993-04-13 | 1998-04-30 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Use of neuro-derived fetal cell lines for transplantation therapy |
| US6653134B2 (en) * | 1995-03-28 | 2003-11-25 | Cp Hahnemann University | Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| WO1999056759A1 (en) * | 1998-05-07 | 1999-11-11 | University Of South Florida | Bone marrow cells as a source of neurons for brain and spinal cord repair |
| GB9904281D0 (en) * | 1999-02-24 | 1999-04-21 | Reneuron Ltd | Transplantation |
-
2000
- 2000-05-11 DK DK00935910T patent/DK1183035T3/en active
- 2000-05-11 ES ES00935910.0T patent/ES2531592T3/es not_active Expired - Lifetime
- 2000-05-11 WO PCT/US2000/012875 patent/WO2000069448A1/en not_active Ceased
- 2000-05-11 PT PT00935910T patent/PT1183035E/pt unknown
- 2000-05-11 AU AU51300/00A patent/AU780994B2/en not_active Ceased
- 2000-05-11 JP JP2000617907A patent/JP2002544234A/ja active Pending
- 2000-05-11 CA CA2373808A patent/CA2373808C/en not_active Expired - Fee Related
- 2000-05-11 EP EP00935910.0A patent/EP1183035B1/en not_active Expired - Lifetime
-
2008
- 2008-10-10 US US12/249,687 patent/US20090162327A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002544234A5 (enExample) | ||
| JP7656642B2 (ja) | 植え込み可能な生きた電極 | |
| US8093205B2 (en) | Method for treating a stroke by implanting a first therapy delivery element in the CNS and a second therapy delivery element in a damaged tissue of the CNS to promote neurogenesis | |
| Koella et al. | Mechanism of the EEG-synchronizing action of serotonin | |
| Riess et al. | Embryonic stem cell transplantation after experimental traumatic brain injury dramatically improves neurological outcome, but may cause tumors | |
| Lindvall | Neural transplantation in Parkinson's disease | |
| US5106627A (en) | Neurological therapy devices | |
| Pettingill et al. | Neurotrophic factors and neural prostheses: potential clinical applications based upon findings in the auditory system | |
| CA2062746C (en) | Neurological therapy system | |
| Shoichet et al. | Cell delivery to the central nervous system | |
| Kim et al. | Acceleration of peripheral nerve regeneration through asymmetrically porous nerve guide conduit applied with biological/physical stimulation | |
| ATE129892T1 (de) | Depotimplantat mit gesteuerter wirkstoffabgabe zur behandlung von krankheiten des nervensystems. | |
| JP2008133285A (ja) | 遺伝的に改変された細胞を含む生体適合性免疫隔離カプセル | |
| CA2373808A1 (en) | Bone marrow transplantation for treatment of central nervous system damage | |
| JP2005516988A (ja) | シュヴァン細胞およびホスホジエステラーゼインヒビターに基づく治療 | |
| Jain | Cell therapy for CNS trauma | |
| JPH06502101A (ja) | 神経系インプラントシステム | |
| Emerich et al. | Neuroprotective effects of encapsulated CNTF-producing cells in a rodent model of Huntington's disease are dependent on the proximity of the implant to the lesioned striatum | |
| Emerich | Dose-dependent neurochemical and functional protection afforded by encapsulated CNTF-producing cells | |
| US20110159056A1 (en) | Methods and materials for stimulating proliferation of stem cells | |
| Aravamudhan et al. | Toward a convergence of regenerative medicine, rehabilitation, and neuroprosthetics | |
| Harbaugh | Neural transplantation vs. central neurotransmitter augmentation in diseases of the nervous system | |
| Strömberg | Intraocular grafting | |
| Fazzini | Transplantation in the treatment of paralysis agitans (Parkinson's disease) | |
| Aravamudhan et al. | ◾ Neural Regenerative Engineering |